Sigma Healthcare (SIG.AX) Stock Price

Sigma Healthcare Price

ASX·CLOSED
2.94AUD-0.02 (-0.68 %)
Market closed

Revenue has compounded at 4.2% per year over the past 19 years to 6.00 B AUD. Earnings per share have declined at 3.6% per year over the last 19 years. Sigma Healthcare's net margin stands at 8.8%, up from -0.2% several years earlier. Sigma Healthcare currently offers a dividend yield of about 0.63%. The payout ratio is around 37% of earnings. Analysts set a median price target of 3.46 AUD, implying 17.6% above the current price. Of 17 analysts, 12 rate the stock a buy — an overall Buy consensus. The stock trades about 13% above its 52-week low.

Sigma Healthcare stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Sigma Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sigma Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sigma Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Sigma Healthcare Stock Price History
DateSigma Healthcare Price
7/31/20262.94 AUD
7/30/20262.96 AUD
7/29/20262.98 AUD
7/28/20262.90 AUD
7/27/20262.85 AUD
7/24/20262.84 AUD
7/23/20262.87 AUD
7/22/20262.89 AUD
7/21/20262.90 AUD
7/20/20262.93 AUD
7/17/20262.93 AUD
7/16/20262.94 AUD
7/15/20262.94 AUD
7/14/20262.92 AUD
7/13/20262.90 AUD
7/10/20262.80 AUD
7/9/20262.87 AUD
7/8/20262.80 AUD
7/7/20262.82 AUD
7/6/20262.82 AUD
7/3/20262.79 AUD
7/2/20262.71 AUD
7/1/20262.76 AUD
6/30/20262.76 AUD
6/29/20262.78 AUD
6/26/20262.78 AUD
6/25/20262.79 AUD
6/24/20262.74 AUD
6/23/20262.74 AUD
6/22/20262.76 AUD
6/19/20262.77 AUD
6/18/20262.82 AUD
6/17/20262.82 AUD
6/16/20262.81 AUD
6/15/20262.82 AUD
6/12/20262.66 AUD
6/11/20262.71 AUD
6/10/20262.76 AUD
6/9/20262.92 AUD
6/5/20262.92 AUD
6/4/20262.90 AUD
6/3/20262.89 AUD
6/2/20262.82 AUD
6/1/20262.92 AUD
5/29/20262.91 AUD
5/28/20262.85 AUD
5/27/20262.85 AUD
5/26/20262.87 AUD
5/25/20262.87 AUD
5/22/20262.87 AUD
5/21/20262.87 AUD
5/20/20262.87 AUD
5/19/20262.85 AUD
5/18/20262.82 AUD
5/15/20262.86 AUD
5/14/20262.86 AUD
5/13/20262.86 AUD
5/12/20262.85 AUD
5/11/20262.84 AUD
5/8/20262.85 AUD
5/7/20262.89 AUD
5/6/20262.92 AUD
5/5/20262.92 AUD
5/4/20262.83 AUD
5/1/20262.81 AUD
4/30/20262.79 AUD
4/29/20262.78 AUD
4/28/20262.75 AUD
4/27/20262.77 AUD
4/24/20262.79 AUD
4/23/20262.81 AUD
4/22/20262.82 AUD
4/21/20262.84 AUD
4/20/20262.78 AUD
4/17/20262.80 AUD
4/16/20262.74 AUD
4/15/20262.70 AUD
4/14/20262.71 AUD
4/13/20262.67 AUD
4/10/20262.69 AUD
4/9/20262.70 AUD
4/8/20262.70 AUD
4/7/20262.67 AUD
4/2/20262.66 AUD
4/1/20262.73 AUD
3/31/20262.65 AUD
3/30/20262.66 AUD
3/27/20262.62 AUD
3/26/20262.62 AUD
3/25/20262.65 AUD
3/24/20262.60 AUD
3/23/20262.67 AUD
3/20/20262.78 AUD
3/19/20262.66 AUD
3/18/20262.68 AUD
3/17/20262.66 AUD
3/16/20262.69 AUD
3/13/20262.64 AUD
3/12/20262.66 AUD
3/11/20262.71 AUD
3/10/20262.74 AUD
3/9/20262.73 AUD
3/6/20262.85 AUD
3/5/20262.80 AUD
2/26/20262.94 AUD
2/25/20262.99 AUD
2/24/20263.00 AUD
2/23/20262.97 AUD
2/20/20262.94 AUD
2/19/20262.98 AUD
2/18/20262.99 AUD
2/17/20263.02 AUD
2/16/20263.01 AUD
2/13/20263.03 AUD
2/12/20263.04 AUD
2/11/20263.09 AUD
2/10/20263.09 AUD
2/9/20263.12 AUD
2/6/20263.13 AUD
2/5/20263.16 AUD
2/4/20263.16 AUD
2/3/20263.14 AUD
2/2/20263.10 AUD
1/30/20263.09 AUD
1/29/20263.09 AUD
1/28/20263.08 AUD
1/27/20263.09 AUD
1/23/20263.06 AUD
1/21/20262.90 AUD
1/20/20262.92 AUD
1/19/20262.87 AUD
1/16/20262.91 AUD
1/15/20262.85 AUD
1/14/20262.85 AUD
1/13/20262.91 AUD
1/12/20262.92 AUD
1/9/20262.89 AUD
1/8/20262.89 AUD
1/7/20262.87 AUD
1/6/20262.83 AUD
1/5/20262.92 AUD
1/2/20262.94 AUD
12/31/20252.95 AUD
12/30/20252.97 AUD
12/29/20252.97 AUD
12/24/20252.98 AUD
12/23/20252.97 AUD
12/22/20252.95 AUD
12/19/20253.00 AUD
12/18/20252.90 AUD
12/17/20252.94 AUD
12/16/20252.97 AUD
12/15/20252.91 AUD
12/12/20252.92 AUD
12/11/20252.90 AUD
12/10/20252.85 AUD
12/9/20252.85 AUD
12/8/20252.81 AUD
12/5/20252.85 AUD
12/4/20252.76 AUD
12/3/20252.80 AUD
12/2/20252.84 AUD
12/1/20252.84 AUD
11/28/20252.88 AUD
11/27/20252.89 AUD
11/26/20252.92 AUD
11/25/20252.91 AUD
11/24/20252.93 AUD
11/21/20252.95 AUD
11/20/20252.94 AUD
11/19/20252.92 AUD
11/18/20252.92 AUD
11/17/20252.93 AUD
11/14/20252.96 AUD
11/13/20253.07 AUD
11/12/20253.13 AUD
11/11/20253.15 AUD
11/10/20253.12 AUD
11/7/20253.11 AUD
11/6/20253.11 AUD
11/5/20253.12 AUD
11/4/20253.10 AUD
11/3/20253.10 AUD
10/31/20253.12 AUD
10/30/20253.11 AUD
10/29/20253.10 AUD
10/28/20253.09 AUD
10/27/20253.08 AUD
10/24/20253.10 AUD
10/23/20253.11 AUD
10/22/20253.06 AUD
10/21/20253.04 AUD
10/20/20252.97 AUD
10/17/20253.03 AUD
10/15/20253.00 AUD
10/14/20253.01 AUD
10/13/20253.03 AUD
10/10/20253.02 AUD
10/9/20253.02 AUD
10/8/20252.93 AUD
10/7/20252.90 AUD
10/6/20252.95 AUD
10/3/20252.99 AUD
10/2/20253.02 AUD
10/1/20252.97 AUD
9/30/20252.97 AUD
9/29/20253.01 AUD
9/26/20253.01 AUD
9/25/20253.01 AUD
9/24/20253.04 AUD
9/23/20253.05 AUD
9/22/20253.04 AUD
9/19/20252.99 AUD
9/17/20252.99 AUD
9/16/20253.01 AUD
9/15/20253.00 AUD
9/12/20252.99 AUD
9/11/20252.99 AUD
9/10/20252.99 AUD
9/9/20253.01 AUD
9/8/20253.04 AUD
9/5/20253.04 AUD
9/4/20253.05 AUD
9/3/20253.08 AUD
9/2/20253.09 AUD
9/1/20253.12 AUD
8/29/20253.12 AUD
8/28/20253.09 AUD
8/27/20253.03 AUD
8/26/20252.81 AUD
8/25/20252.88 AUD
8/22/20252.85 AUD
8/21/20252.85 AUD
8/20/20252.82 AUD
8/19/20252.83 AUD
8/18/20252.87 AUD
8/15/20252.84 AUD
8/14/20252.86 AUD
8/13/20252.86 AUD
8/12/20252.86 AUD
8/11/20252.84 AUD
8/8/20252.86 AUD
8/7/20252.87 AUD
8/6/20252.88 AUD
8/5/20252.89 AUD
8/4/20252.87 AUD
Access this data via the Eulerpool API
Get Free API Key

Sigma Healthcare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
3.42 B AUD
23.20 M AUD
4.51 M AUD
Jan 1, 2024
4.93 B AUD
21.66 M AUD
-13.84 M AUD
Jan 1, 2025
6.00 B AUD
737.67 M AUD
529.91 M AUD
Jan 1, 2026 (e)
10.87 B AUD
68.69 M AUD
680.11 M AUD
Jan 1, 2027 (e)
12.09 B AUD
76.43 M AUD
808.11 M AUD
Jan 1, 2028 (e)
13.26 B AUD
83.84 M AUD
940.98 M AUD
Jan 1, 2029 (e)
14.97 B AUD
94.59 M AUD
1.18 B AUD
Jan 1, 2030 (e)
16.44 B AUD
103.93 M AUD
1.37 B AUD

Sigma Healthcare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 3, 2026, 6:59 PM
 
REVENUEB AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEB AUD
NET INCOME GROWTH%
DIV.AUD
DIV. GROWTH%
SHARESB
20162017201820192020202120222023202420252026e2027e2028e2029e2030e2031e
4.444.214.083.343.513.553.763.424.936.0010.8712.0913.2614.9716.4414.32
25.83-5.20-3.25-17.964.971.145.97-9.1544.1321.8581.0911.279.6812.839.88-12.91
8.248.719.109.399.929.619.479.167.4124.0024.0024.0024.0024.0024.0024.00
0.370.370.370.310.350.340.360.310.371.442.612.903.183.593.953.44
92.0083.0061.00-1.0010.003.0032.0023.0021.00737.0068.0076.0083.0094.00103.00–
2.071.971.50-0.030.280.080.850.670.4312.280.630.630.630.630.63–
0.050.060.04-0.010.04-0.01––-0.010.530.680.810.941.181.371.15
6.003.77-34.55-133.33-458.33-116.28-114.29300.00-425.00-4,169.2328.5418.8216.3425.7416.16-15.95
0.080.070.060.040.040.030.030.010.010.020.040.040.04–––
33.33-12.50-14.29-33.33–-25.00–-66.67–100.00100.00–––––
1.071.051.010.971.051.021.051.061.5710.4910.4910.4910.4910.4910.4910.49
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Sigma Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sigma Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sigma Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Sigma Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sigma Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Sigma Healthcare stock margins

The Sigma Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sigma Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sigma Healthcare.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
9.61 %
0.11 %
-0.20 %
Jan 1, 2022
9.47 %
0.87 %
0.05 %
Jan 1, 2023
9.17 %
0.68 %
0.13 %
Jan 1, 2024
7.43 %
0.44 %
-0.28 %
Jan 1, 2025
24.00 %
12.29 %
8.83 %
Jan 1, 2026 (e)
24.00 %
0.63 %
6.26 %
Jan 1, 2027 (e)
24.00 %
0.63 %
6.68 %
Jan 1, 2028 (e)
24.00 %
0.63 %
7.09 %

Sigma Healthcare Stock Revenue, EBIT, Earnings per Share

The Sigma Healthcare earnings per share therefore indicates how much revenue Sigma Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
3.49 AUD
0.00 AUD
-0.01 AUD
Jan 1, 2022
3.60 AUD
0.03 AUD
0.00 AUD
Jan 1, 2023
3.21 AUD
0.02 AUD
0.00 AUD
Jan 1, 2024
3.13 AUD
0.01 AUD
-0.01 AUD
Jan 1, 2025
0.57 AUD
0.07 AUD
0.05 AUD
Jan 1, 2026 (e)
1.04 AUD
0.01 AUD
0.06 AUD
Jan 1, 2027 (e)
1.15 AUD
0.01 AUD
0.08 AUD
Jan 1, 2028 (e)
1.26 AUD
0.01 AUD
0.09 AUD

Sigma Healthcare business model & stock analysis

Sigma Healthcare Ltd is an Australian company that has been operating in the healthcare industry for over 100 years. Founded in 1911 as a local pharmacy in Melbourne, the company has since become a leading provider of pharmaceutical services in Australia. The company's core business is the delivery of pharmacy products and services to pharmacies and medical practices across Australia. Sigma Healthcare Ltd supplies over 4,000 independent retailers as well as numerous large chains and department store pharmacies. Sigma Healthcare Ltd also offers various healthcare services, such as consulting, training, and support in medication delivery. Divided into different divisions, Sigma Healthcare Ltd offers a wide portfolio of products. In the pharmaceutical products division, the company distributes national and international medications, both prescription and over-the-counter. Additionally, health and personal care products such as medical devices, supplements, vitamins, and minerals are available. The general products division offers a variety of non-food products, such as personal care products, wellness products, hygiene products, cleaning agents, cosmetics, and household products. Another important division is the pharmacy management system, which supports pharmacies in managing their business and billing processes. The system complements the existing offering with additional features, such as inventory management, prescription processing, accounting, and customer loyalty. Innovation plays a central role at Sigma Healthcare Ltd. The company invests significant resources in researching and developing new products and services to continuously improve the customer experience and meet the ever-growing demands of the industry. The company benefits from close relationships with leading manufacturers and international organizations. Partnerships are another crucial aspect of Sigma Healthcare Ltd's business model. The company works closely with manufacturers, retailers, pharmacists, and other partners to jointly create innovative solutions and products to enhance the customer experience. In recent years, Sigma Healthcare Ltd has also pursued a significant growth strategy, such as acquiring companies that complement its existing portfolio. This includes the acquisition of API in 2020 and Discount Drug Stores in 2018, which have greatly expanded the offerings of Sigma Healthcare Ltd. Overall, Sigma Healthcare Ltd is an important company in the Australian healthcare industry. With a wide range of products and services, a strong culture of innovation, and significant partnerships with industry players, the company will continue to establish itself as a key player in healthcare and continuously improve the customer experience.

Sigma Healthcare SWOT Analysis

Strengths

1. Strong market presence: Sigma Healthcare Ltd has established itself as a leading player in the healthcare industry.

2. Diverse product portfolio: The company offers a wide range of pharmaceutical and medical products, catering to various customer needs.

3. Strategic partnerships: Sigma Healthcare has forged strong partnerships with major suppliers, enabling them to access a diverse range of products and deliver value to customers.

4. Broad distribution network: The company has an extensive distribution network that ensures efficient and timely delivery of products to pharmacies and hospitals.

5. Strong financial position: Sigma Healthcare enjoys a stable financial position, which provides them with the resources to invest in growth opportunities and innovation.

Weaknesses

1. Dependence on suppliers: Sigma Healthcare heavily relies on its suppliers for the availability of products, which exposes them to potential supply chain disruptions.

2. Vulnerability to regulatory changes: The company operates in a highly regulated industry, making it susceptible to changes in government policies and regulations.

3. Limited international presence: While Sigma Healthcare has a strong presence within the domestic market, their international reach is limited, potentially hindering expansion into global markets.

4. Competitive market: The healthcare industry is highly competitive, and Sigma Healthcare faces competition from both traditional and online pharmacies, which could impact market share.

Opportunities

1. Growing healthcare industry: With the increasing demand for healthcare products and services, Sigma Healthcare can capitalize on this opportunity to expand its customer base and market share.

2. Technological advancements: The adoption of digital technologies in the healthcare sector opens up avenues for Sigma Healthcare to enhance operational efficiency and improve customer experience.

3. Expansion into emerging markets: Exploring and entering emerging markets can provide Sigma Healthcare with new growth opportunities and access to a larger customer base.

Threats

1. Economic fluctuations: Sigma Healthcare may be affected by economic downturns, which could impact consumer spending on healthcare products and services.

2. Price competition: The presence of low-cost competitors within the industry may put pressure on Sigma Healthcare's pricing strategy.

3. Technological disruption: Rapid advancements in technology may disrupt traditional distribution models, requiring Sigma Healthcare to adapt and invest in new systems and infrastructure.

4. Regulatory challenges: Tightening of regulations or changes in government policies can impose compliance burdens on Sigma Healthcare and increase operational costs.

Sigma Healthcare Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Sigma Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

Sigma Healthcare annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Sigma Healthcare shares outstanding

The number of shares of Sigma Healthcare was 10.49 B in 2025. This indicates how many shares Sigma Healthcare is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
1.02 B Stocks
Jan 1, 2022
1.05 B Stocks
Jan 1, 2023
1.06 B Stocks
Jan 1, 2024
1.57 B Stocks
Jan 1, 2025
10.49 B Stocks
Jan 1, 2026 (e)
10.49 B Stocks
Jan 1, 2027 (e)
10.49 B Stocks
Jan 1, 2028 (e)
10.49 B Stocks

Sigma Healthcare stock splits

In Sigma Healthcare's history, there have been no stock splits.

Sigma Healthcare Dividend History

22 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.02AUD↑ 67.7%1×
Sep 2, 20250.02AUD↑ 271.4%1/1
20240.01AUD↓ 22.5%2×
20230.01AUD↓ 33.3%2×
20220.02AUD↓ 25.0%2×
20210.03AUD↓ 33.3%2×
20200.04AUD↑ 0.0%—
20190.04AUD↓ 25.0%2×
20180.06AUD↓ 27.3%2×
20170.08AUD 0.0%2×
20160.08AUD↑ 37.5%2×

Sigma Healthcare dividend history and estimates

In 2025, Sigma Healthcare paid a dividend amounting to 0.02 AUD. Dividend means that Sigma Healthcare distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021 (e)
0.03 AUD
0.00 AUD
0.00 AUD
Jan 1, 2022 (e)
0.02 AUD
0.01 AUD
0.00 AUD
Jan 1, 2023
0.01 AUD
0.00 AUD
0.00 AUD
Jan 1, 2024
0.01 AUD
0.00 AUD
0.00 AUD
Jan 1, 2025
0.02 AUD
0.00 AUD
0.00 AUD
Jan 1, 2026 (e)
0.02 AUD
0.02 AUD
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
0.04 AUD
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
0.04 AUD
0.00 AUD

Sigma Healthcare dividend payout ratio

In 2025, Sigma Healthcare had a payout ratio of 36.78%. The payout ratio indicates the percentage of the company's profits that Sigma Healthcare distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
-402.41 %
Jan 1, 2022
1,224.20 %
Jan 1, 2023
330.34 %
Jan 1, 2024
-125.81 %
Jan 1, 2025
36.78 %
Jan 1, 2026 (e)
57.26 %
Jan 1, 2027 (e)
48.19 %
Jan 1, 2028 (e)
41.39 %

Current Sigma Healthcare forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.35 %
Buy
70.59 % (12)
Hold
29.41 % (5)
Sell
0.00 % (0)
12M Price Target
3.46
Last Price
2.95
Currency
AUD
12M Return Potential
17.02 %
LTM Return
0 %

Sigma Healthcare Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
3/29/20240.00AUD-1.72 BAUD-2024 Q4
3/22/20230.01AUD-1.70 BAUD-2023 Q4
9/26/2022-AUD-1.69 BAUD-2023 Q2
3/29/20220.02AUD-1.82 BAUD-2022 Q4
9/21/20210.02AUD-1.90 BAUD-2022 Q2
3/23/20210.02AUD-1.92 BAUD-2021 Q4
9/10/20200.01AUD-1.89 BAUD-2021 Q2
3/25/2020-AUD-1.12 BAUD-2020 Q4
9/13/20120.02AUD-1.41 BAUD-2013 Q2
3/22/20120.02AUD-1.50 BAUD-2012 Q4

EESG©

Eulerpool ESG Scorecard© for the Sigma Healthcare stock

57/100
65
Environment
73
Social
33
Governance
E

Environment

20
Scope 1 - Direct Emissions7.57
Scope 2 - Indirect emissions from purchased energy6,594
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions6,601
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees64
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Sigma Healthcare shareholder structure

% Name
1.27554%
Gance (Damien)
Gance (Damien)
0.93546%
Vanguard Investments Australia Ltd.
Vanguard Investments Australia Ltd.
0.84668%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.72131%
Pilla (Danielle Di)
Pilla (Danielle Di)
0.34501%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
0.25290%
BlackRock Advisors (UK) Limited
BlackRock Advisors (UK) Limited
...

Sigma Healthcare Beneficial Ownership Filings (SEC 13D/G)

Free Float
43.9%
Float Shares
-
Shares Outstanding
-

Sigma Healthcare Executives and Management Board

9 members · avg. age 63 · 33 % women

VR

Mr. Vikesh Ramsunder (51)

Chief Executive Officer, Managing Director, Executive Director · since 2022

3.38 M AUD

Management

MC

Mr. Mark Conway

Chief Financial Officer

486,262.00 AUD
KM

Ms. Kara Mcgowan

General Counsel, Company Secretary

–
GW

Mr. Gary Woodford

Head of Corporate Affairs

–

Board of Directors

MS

Mr. Michael Sammells

Non-Executive Chairman of the Board

461,085.00 AUD
NM

Mr. Neville Mitchell (64)

Non-Executive Director

199,538.00 AUD
KS

Ms. Kathryn Spargo (71)

Non-Executive Director

174,883.00 AUD
AC

Ms. Annette Carey

Non-Executive Director

124,706.00 AUD
CR

Dr. Christopher Roberts (65)

Non-Executive Director

47,680.00 AUD

Sigma Healthcare Supply Chain

Sigma Healthcare Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#NameTrend
1
Strides Pharma Science
Supplier·IN
0.61
0.33
0.22
-0.32
0.81
0.64
2
CellSeed
Supplier·Biotechnology·JP
-0.64
-0.31
-0.42
-0.43
0.74
0.63
#NameTrend
1
Elanor Retail Property
Supplier·Equity Real Estate Investment Trusts (REITs)·AU
0.31
0.15
0.50
0.10
-0.50
—

Frequently asked questions about Sigma Healthcare

Sigma Healthcare Ltd operates as a leading healthcare distribution company in Australia. With a robust business model, the company focuses on providing comprehensive pharmacy services, wholesale distribution, and retail support to pharmacy customers across the nation. Sigma Healthcare aims to enhance patient health outcomes by ensuring the timely delivery of pharmaceuticals, healthcare products, and related services. By leveraging its extensive network, advanced technology, and strategic partnerships, Sigma Healthcare efficiently manages the supply chain, optimizes inventory, and assists pharmacies in delivering quality healthcare solutions. Through its customer-centric approach and commitment to innovation, Sigma Healthcare upholds its position as a trusted provider in the Australian healthcare industry.

Sigma Healthcare Ltd is primarily active in the pharmaceutical and healthcare industries.

The main competitors of Sigma Healthcare Ltd in the market include Australian Pharmaceutical Industries Limited (API), Ramsay Health Care Limited, and Medibank Private Limited.

Sigma Healthcare Ltd is an Australian pharmacy and healthcare company with a rich history. Established in 1912, Sigma Healthcare has evolved into a leading player in the pharmaceutical industry, providing a wide range of healthcare solutions. The company operates multiple business segments, including wholesale, retail pharmacy, and distribution. It partners with various pharmaceutical manufacturers and suppliers to deliver high-quality products and services to customers. Sigma Healthcare's commitment to innovation, customer satisfaction, and its extensive network of pharmacies has propelled its growth over the years. With a strong presence in the Australian market, Sigma Healthcare Ltd continues to contribute to the nation's healthcare landscape.

Sigma Healthcare Ltd has achieved several significant milestones throughout its history. Some noteworthy achievements include the acquisition of Central Healthcare Services in 2001, which strengthened its position in the pharmacy wholesale market. In 2010, Sigma Healthcare successfully merged with Australian Pharmaceutical Industries, enhancing its capabilities and expanding its reach in the healthcare sector. The company also established SigmaPharm, a state-of-the-art manufacturing facility in 2015, enabling it to produce high-quality generic pharmaceutical products. Furthermore, Sigma Healthcare partnered with Arrow Pharmaceuticals in 2018, forming a strategic alliance that aimed to optimize their respective supply chain networks. These milestones contribute to Sigma Healthcare Ltd's ongoing growth and success in the healthcare industry.

Sigma Healthcare Ltd is primarily present in Australia.

Sigma Healthcare Ltd represents a strong commitment to providing quality healthcare solutions. The company believes in delivering reliable and accessible pharmaceutical products and services to improve patient outcomes. With a customer-centric approach, Sigma Healthcare focuses on building lasting relationships with healthcare providers and stakeholders. The company's corporate philosophy revolves around fostering innovation, collaboration, and integrity within the healthcare industry. Sigma Healthcare aims to create value for its customers and shareholders while ensuring the highest standards of ethical conduct. Through its extensive network and expertise, Sigma Healthcare strives to enhance healthcare delivery and contribute to the well-being of communities.

Analysts currently set an average price target of 3.42 AUD for the Sigma Healthcare stock (median: 3.46 AUD), implying +15.9 % versus the latest price. The consensus is based on 17 analyst ratings.

Sigma Healthcare Analyst Price Targets 2026

17 analysts currently rate the Sigma Healthcare stock: 12 recommend buying, 5 holding and 0 selling. For 2026, analysts expect Sigma Healthcare to generate revenue of 10.87 B AUD and earnings per share of 0.06 AUD.

Sigma Healthcare Analyst Price Targets 2026

Converted at the current exchange rate, the Sigma Healthcare share trades at 1.79 EUR (2.94 AUD).

The Sigma Healthcare share (SIG.AX) is listed on 3 stock exchanges, including: Frankfurt (S5YA.F), Düsseldorf (S5YA.DU), ASX (SIG.AX).

Sigma Healthcare Ltd is a leading provider of pharmacy products and services in Australia and New Zealand. The company has been operating in the industry for over 100 years and has established itself as a trusted partner for pharmacies and healthcare facilities. The company's business model is based on three main divisions: 1. Wholesale distribution: Sigma Healthcare Ltd's wholesale division offers a wide range of pharmaceutical products, medical devices, consumables, and other health products. The company works closely with pharmacies and healthcare facilities to ensure they have access to the latest and highest quality products. 2. Retail: Sigma Healthcare Ltd also operates a wide range of retail brands, including Amcal, Guardian, and Discount Drug Stores. These brands offer a variety of health products and services, including over-the-counter medications, beauty products, health checks, consultations, and more. 3. Healthcare sector services: Sigma Healthcare Ltd also offers a range of services for the healthcare sector. These include logistics and warehousing services, marketing and advertising services, financial and accounting, information technology, and pharmacy management. The company works closely with healthcare facilities and pharmacies to ensure they operate efficiently and effectively while ensuring high-quality care for their patients. The company offers a wide range of products, including over-the-counter and prescription medications, dietary supplements, medical devices, consumables, hygiene products, beauty products, and more. Sigma Healthcare Ltd collaborates with a variety of international and local manufacturers to ensure they can offer their customers the best products at competitive prices. Innovation plays a key role in Sigma Healthcare Ltd's business model. The company continuously invests in new technologies and systems to ensure it meets the needs of its customers and the healthcare industry. For example, the company recently invested in a new automated warehouse system that has improved the efficiency and accuracy of order processing. Sigma Healthcare Ltd is also committed to playing a leading role in the healthcare sector. The company works closely with government agencies, NGOs, and other organizations to improve the delivery of healthcare services and products. It also has a strong environmental and social responsibility and actively engages in sustainability, workplace safety, community development, and engagement. In conclusion, Sigma Healthcare Ltd is a leading provider of pharmacy products and services in Australia and New Zealand. The company offers a wide range of products and services, including wholesale, retail, and healthcare sector services. Sigma Healthcare Ltd utilizes innovative technologies and systems to operate efficiently and effectively, and to provide its customers with the best health products and services. It also has a strong environmental and social responsibility and actively engages in sustainability and community development.

The expected revenue of Sigma Healthcare is 10.87 B AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Sigma Healthcare is 680.11 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Sigma Healthcare is currently 45.32. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sigma Healthcare stock.

The price-to-sales ratio (P/S) of Sigma Healthcare is currently 2.84. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sigma Healthcare stock.

The Eulerpool Quality Score for Sigma Healthcare is 6/10.

The ISIN of Sigma Healthcare is AU000000SIG5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Sigma Healthcare is A2DYWB. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Sigma Healthcare is SIG.AX. The ticker symbol is used to trade Sigma Healthcare shares on the stock exchange.

Over the past 12 months, Sigma Healthcare paid a dividend of 0.02 AUD . This corresponds to a dividend yield of about 0.63 %. For the coming 12 months, Sigma Healthcare is expected to pay a dividend of 0.04 AUD.

The current dividend yield of Sigma Healthcare is 0.63 %.

Sigma Healthcare pays a dividend, distributed in the months of , , , .

Sigma Healthcare paid dividends every year for the past 5 years.

For the upcoming 12 months, dividends amounting to 0.04 AUD are expected. This corresponds to a dividend yield of 1.26 %.

Sigma Healthcare is assigned to the 'Health' sector.

To receive the latest dividend of Sigma Healthcare from amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Sigma Healthcare distributed 0.01 AUD as dividends.

The dividends of Sigma Healthcare are distributed in AUD.

All fundamentals and in-depth analysis of Sigma Healthcare

Our stock analysis for Sigma Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sigma Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Sigma Healthcare Stock
Sigma Healthcare Revenue→
Sigma Healthcare Stock
Sigma Healthcare Net Income→
Sigma Healthcare Stock
Sigma Healthcare P/E→
Sigma Healthcare Stock
Sigma Healthcare P/S→
Sigma Healthcare Stock
Sigma Healthcare EBIT→
Sigma Healthcare Stock
Sigma Healthcare Dividend→
Sigma Healthcare Stock
Sigma Healthcare Directors Dealings→
Sigma Healthcare Stock
Sigma Healthcare Stocks→
Sigma Healthcare Stock
Sigma Healthcare Market capitalization→
Sigma Healthcare Stock
Sigma Healthcare Debt→
Sigma Healthcare Stock
Sigma Healthcare Liabilities→
Sigma Healthcare Stock
Sigma Healthcare Equity→
Sigma Healthcare Stock
Sigma Healthcare AAQS→
Sigma Healthcare Stock
Sigma Healthcare Employees→
Sigma Healthcare Stock
Sigma Healthcare ROE→
Sigma Healthcare Stock
Sigma Healthcare ROA→
Sigma Healthcare Stock
Sigma Healthcare ROCE→
Sigma Healthcare Stock
Sigma Healthcare News→
Sigma Healthcare Stock
Sigma Healthcare Analyst Price Targets→

Health Stocks

Sikarin PCLSight SciencesSilence TherapeuticsSigachi IndustriesSilk Laser AustraliaSIGA TechnologiesSillaJenSienna Senior LivingSilo PharmaSienna BiopharmaceuticalsSiloam International Hospitals Tbk PTSiemens HealthineersAll Stocks A–Z →